NOVEL HDAC INHIBITORS

Abstract The present invention relates to novel compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions. The present invention more particularly provides novel HDAC inhibitor...

Full description

Saved in:
Bibliographic Details
Main Authors REDDY, GADDAM, OM, MANIKANDAN, LAKSHMANAN, RAJAGOPAL, SRIRAM, NARASIMHAN, KILAMBI, SELVAKUMAR, THANGAPAZHAM, SRINIVAS, AKELLA, SATYA, SURYA, VISWESWARA
Format Patent
LanguageEnglish
French
Published 21.08.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The present invention relates to novel compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions. The present invention more particularly provides novel HDAC inhibitors of the general formula (1). Also included is a method for treatment of cancer, psoriasis, proliferative conditions and conditions mediated by HDAC, in a mammal comprising administering an effective amount of a compound of formula (I) as described above. La présente invention a trait à de nouveaux composés de formule générale (1), leurs dérivés, analogues, formes tautomères, stéréoisomères, formes polymorphes, hydrates, solvates, et sels et compositions pharmaceutiquement acceptables. Plus particulièrement, la présente invention a trait à de nouveaux inhibiteurs HDAC de formule générale (I). La présente invention a également trait à un procédé pour le traitement du cancer, de psoriasis, de conditions prolifératives et de conditions médiées par HDAC, chez un mammifère comprenant l'administration d'une quantité efficace d'un composé de formule générale (I) de l'invention.
Bibliography:Application Number: WO2006IB02890